SI1652535T1 - Poltrdni mukoadhezivni pripravki - Google Patents

Poltrdni mukoadhezivni pripravki

Info

Publication number
SI1652535T1
SI1652535T1 SI200431522T SI200431522T SI1652535T1 SI 1652535 T1 SI1652535 T1 SI 1652535T1 SI 200431522 T SI200431522 T SI 200431522T SI 200431522 T SI200431522 T SI 200431522T SI 1652535 T1 SI1652535 T1 SI 1652535T1
Authority
SI
Slovenia
Prior art keywords
semi
mucoadhesive formulations
solid
solid mucoadhesive
formulations
Prior art date
Application number
SI200431522T
Other languages
English (en)
Inventor
Fernandez Alvaro Acebron
Garcia Ana Campuzano
Martin Rosa Maria Hernandez
Olaechea Manuela Igartua
Munoz Jose Luis Pedraz
Gascon Alicia Rodriguez
Original Assignee
Italfarmaco Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Sa filed Critical Italfarmaco Sa
Publication of SI1652535T1 publication Critical patent/SI1652535T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Adhesive Tapes (AREA)
SI200431522T 2003-07-16 2004-07-16 Poltrdni mukoadhezivni pripravki SI1652535T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200301672A ES2237298B1 (es) 2003-07-16 2003-07-16 Formulaciones mucoadhesivas semisolidas.
EP04742064A EP1652535B1 (en) 2003-07-16 2004-07-16 Semi-solid mucoadhesive formulations
PCT/ES2004/000336 WO2005007194A1 (es) 2003-07-16 2004-07-16 Formulaciones mucoadhesivas semisólidas

Publications (1)

Publication Number Publication Date
SI1652535T1 true SI1652535T1 (sl) 2010-12-31

Family

ID=34072910

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431522T SI1652535T1 (sl) 2003-07-16 2004-07-16 Poltrdni mukoadhezivni pripravki

Country Status (13)

Country Link
US (1) US8663688B2 (sl)
EP (2) EP1652535B1 (sl)
JP (1) JP4891765B2 (sl)
AT (1) ATE482723T1 (sl)
CY (1) CY1110954T1 (sl)
DE (1) DE602004029369D1 (sl)
DK (1) DK1652535T3 (sl)
ES (2) ES2237298B1 (sl)
HR (1) HRP20100635T1 (sl)
PL (1) PL1652535T3 (sl)
PT (1) PT1652535E (sl)
SI (1) SI1652535T1 (sl)
WO (1) WO2005007194A1 (sl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1667619A4 (en) 2003-09-19 2007-10-10 Drugtech Corp PHARMACEUTICAL FEEDING SYSTEM
EP1896078A1 (en) * 2005-06-16 2008-03-12 Warner Chilcott Company, Inc. Estrogen compositions for vaginal administration
WO2006138686A1 (en) * 2005-06-16 2006-12-28 Warner Chilcott Company, Inc. Estrogen compositions for vaginal administration
EP1898880A2 (en) * 2005-06-16 2008-03-19 Warner Chilcott Company Inc. Gel compositions for topical administration
MX2008001687A (es) * 2005-08-12 2008-02-19 Drugtech Corp Composiciones de estrogenos y metodos terapeuticos de uso.
CA2637608A1 (en) * 2006-01-20 2007-07-26 Pear Tree Pharmaceuticals, Inc. Method of treating atrophic vaginitis
EP2018164B1 (de) 2006-05-12 2017-03-01 Christian Noe Verwendung von kombinationspräparaten, umfassend antimykotika
WO2007143607A2 (en) * 2006-06-02 2007-12-13 Pear Tree Women's Health Care Method of treating atrophic vaginitis
WO2008005783A2 (en) * 2006-06-30 2008-01-10 Drugtech Corporation Treatment of non- infectious inflammatory vulvovaginitis with a bioadhesive clindamycin composition
ES2310968B1 (es) * 2007-06-25 2010-02-08 Italfarmaco, S.A. Uso de estriol en bajas dosis.
ES2344673B1 (es) * 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
KR20110043661A (ko) * 2008-08-12 2011-04-27 노바베이 파마슈티칼즈, 인코포레이티드 항미생물 젤 제형물
BRPI0803568B8 (pt) * 2008-08-14 2021-05-25 Biolab San Us Farm Ltda composição mucoaderente
ES2344675B1 (es) * 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
US8834927B2 (en) * 2010-04-01 2014-09-16 Pharmanest Ab Thermogelling anaesthetic compositions
CN102293735B (zh) * 2011-08-19 2013-05-01 辽宁万嘉医药科技有限公司 一种抗真菌咪唑类药物缓释凝胶和制备方法
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
CN102600288B (zh) * 2012-04-20 2014-03-05 广西源安堂药业有限公司 一种治疗阴道炎的复方黄松凝胶药物及其制备方法
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
KR101358993B1 (ko) 2012-09-05 2014-02-06 임혜선 네일 프린팅용 트랜스퍼 솔루션 및 이를 이용한 네일 프린팅 방법
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
AU2015296609A1 (en) 2014-07-29 2016-12-22 Therapeuticsmd, Inc. Transdermal cream
US20160175271A1 (en) * 2014-12-19 2016-06-23 Gavis Pharmaceuticals Rectal suppository for ulcerative colitis
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
JP7055754B2 (ja) * 2016-01-07 2022-04-18 ヴィラマル リミテッド 角質層および血清中の薬物濃度を最大にするための経皮送達用ゲル組成物ならびにそれを使用する方法
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CA3117842A1 (en) 2018-10-26 2020-04-30 Viramal Limited Mucoadhesive gel composition
EP3659583B1 (en) 2018-11-30 2023-06-07 Viramal Limited A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent
CN110151680A (zh) * 2019-04-10 2019-08-23 重庆医药高等专科学校 雌三醇凝胶产品及制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU565354B2 (en) 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
NZ222698A (en) 1987-01-08 1990-02-26 Squibb & Sons Inc Bioadhesive suppository formulations comprising a medicament, water, a hydrocolloid and low melting point base
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
JP2510052B2 (ja) 1989-10-31 1996-06-26 コロンビア ラボラトリーズ インコーポレイテッド 組織与湿組成物及び方法
EP0431719B1 (en) 1989-10-31 1994-11-09 Columbia Laboratories, Inc. Vaginal tissue moisturizing composition
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
US5667492A (en) 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
US5741525A (en) 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
AU714797B2 (en) 1996-06-14 2000-01-13 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes, methods of making and use thereof
IT1284874B1 (it) 1996-08-02 1998-05-22 Farmigea Spa Complessi bioadesivi di polycarbophil e farmaci antifungini o antiprotozoari azolici
US5942243A (en) 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
CA2271843A1 (en) 1996-11-14 1998-05-22 Lipomedica Ehf. Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections
DE69819748T2 (de) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US6159491A (en) 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
AU4673099A (en) 1999-02-26 2000-09-14 Chiron Corporation Use of bioadhesives and adjuvants for the mucosal delivery of antigens
SE522260C2 (sv) 1999-10-01 2004-01-27 Ericsson Telefon Ab L M Metod, system och säkerhetsadapter för att exekvera säker dataöverföring i ett trådlöst nät
UA74168C2 (uk) 1999-10-05 2005-11-15 Коламбіа Леборетеріс (Бермуда) Лімітед Лікування ендометріозу або безпліддя, або покращення плідності та застосування бета-адренергічного агоніста для виробництва лікарського засобу
WO2001028515A1 (en) * 1999-10-22 2001-04-26 Líf-Hlaup ehf. Bio-Gels Pharmaceuticals Inc. Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion
AR030312A1 (es) * 2000-08-03 2003-08-20 Antares Pharma Ipl Ag Composicion novedosa para la administracion transdermica y/o transmucosica de compuestos activos, que asegura adecuados niveles terapeuticos
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US6967194B1 (en) * 2002-09-18 2005-11-22 Susan Matsuo Bio-identical hormones and method of use
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.

Also Published As

Publication number Publication date
ES2237298A1 (es) 2005-07-16
ES2237298B1 (es) 2006-11-01
DK1652535T3 (da) 2010-11-15
US8663688B2 (en) 2014-03-04
ATE482723T1 (de) 2010-10-15
ES2353694T3 (es) 2011-03-04
PT1652535E (pt) 2010-11-18
JP4891765B2 (ja) 2012-03-07
JP2007528864A (ja) 2007-10-18
WO2005007194A1 (es) 2005-01-27
EP1652535A1 (en) 2006-05-03
EP2100612A3 (en) 2010-06-02
HRP20100635T1 (hr) 2010-12-31
EP2100612A2 (en) 2009-09-16
CY1110954T1 (el) 2015-06-11
PL1652535T3 (pl) 2011-03-31
DE602004029369D1 (de) 2010-11-11
EP1652535B1 (en) 2010-09-29
US20060240111A1 (en) 2006-10-26

Similar Documents

Publication Publication Date Title
PL1652535T3 (pl) Półstałe formulacje mukoadhezyjne
PT1446122E (pt) Utilizacao de flibanserina no tratamento de disturbios de desejo sexual
HRP20020593B1 (en) Brain, spinal and nerve injury treatment
WO2003014309A3 (en) Interleukin-1 receptors in the treatment of diseases
EP1688425A3 (en) Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
IL172423A0 (en) Novel formulations for opioid -based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
HK1091209A1 (en) 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
TR200800691T2 (tr) Miyelin kaybettiren hastalıkların ya da durumların tedavi yöntemi.
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
EP1406648A4 (en) USE OF ANGIOTENSIN I DERIVATIVE AGENT FOR THE TREATMENT AND PREVENTION OF INFECTIOUS HEART DAMAGE AND DISEASES
CY1106702T1 (el) Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων
WO2006062980A3 (en) Stable non-crystalline formulation comprising tiagabine
WO2002051404A8 (fr) Compositions orales
IT1318509B1 (it) Polimeri reticolati, utili per uso farmaceutico, medicale e cosmetico.
WO2002067951A3 (de) Verwendung von 5-substituierten nukleosiden und/oder deren prodrugs zur resistenzfreien therapie von infektionskrankheiten
RU2000104127A (ru) Штамм bacillus subtilis x-15, используемый для профилактики и лечения эндометритов у коров
WO2004006900A3 (en) Sulphydryl compounds in combination with sulphone or sulphnamide conpounds for use in microbial inflammatory diseases
PL355292A1 (en) Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics
ITBO20000360A0 (it) Apparecchiatura di elettrostimolazione del corpo umano .
ES2159479A1 (es) Nuevos indazoles como inhibidores de la ciclooxigenasa-ii
AU2002357691A1 (en) Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
Kozlowski Personal space of the brain injured
UA36410A (uk) Спосіб аудіометричного обстеження слухової системи людини
Ma'rifat et al. Women as Viewed by the Qur'an and in the Time of Revelation
WHO Tobacco Free Initiative Advancing knowledge on regulating tobacco products: monograph